GRAIL
Grail develops a pan-cancer screening test designed to detect cancers at an early stage. Its pan-cancer screening test measures circulating nucleic acids in blood using high-intensity sequencing, population-scale clinical trials, enabling doctors to develop blood tests for early-stage cancer detection. The company was founded in 2016 by Alex Aravanis and Jeff Huber in Menlo Park, California.
GRAIL
Industry:
Biotechnology Health Care Health Diagnostics Medical Medical Device
Founded:
2016-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.grail.com
Total Employee:
501+
Status:
Active
Contact:
+1 650 542 0372
Email Addresses:
[email protected]
Total Funding:
2 B USD
Technology used in webpage:
SPF SSL By Default Content Delivery Network Domain Not Resolving Google Apps For Business Microsoft Azure DNS Google Google Cloud Amazon Route 53 Java EE
Similar Organizations
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
HiberCell
HiberCell is a biotechnology company developing treatments to prevent cancer relapse and metastasis.
Eva
Eva develops an accessible and non-invasive wearable device designed to detect breast cancer risks.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
MedicaMetrix
Advancing Prostate Disease Management
NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
NurLabs
NurLabs develops label-free and reagent-free diagnostics to detect cancer early when it is most treatable.
Current Advisors List
Current Employees Featured
Founder
Investors List
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board investment in Series D - Grail
Huangpu River Capital
Huangpu River Capital investment in Series D - Grail
Illumina
Illumina investment in Series D - Grail
PSP Investments
PSP Investments investment in Series D - Grail
China Merchants Securities
China Merchants Securities investment in Series C - Grail
Hillhouse Capital Group
Hillhouse Capital Group investment in Series C - Grail
Ally Bridge Group
Ally Bridge Group investment in Series C - Grail
Genuity Science
Genuity Science investment in Series C - Grail
Blue Pool Capital
Blue Pool Capital investment in Series C - Grail
Sequoia Capital China
Sequoia Capital China investment in Series C - Grail
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-14 | Illumina Appoints Bob Ragusa as Chief Executive Officer (CEO) of GRAIL |
| 2019-12-16 | GRAIL Appoints Gautam Kollu as Chief Commercial Officer | GRAIL |
Official Site Inspections
http://www.grail.com Semrush global rank: 606.1 K Semrush visits lastest month: 74.53 K
- Host name: server-3-171-76-66.iad89.r.cloudfront.net
- IP address: 3.171.76.66
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Grail"
Home - The Grail in the USA
The Grail in the US is a movement where all members are encouraged to advance our shared vision in the manner that best befits their interests, abilities and the needs of their community. …See details»
Leadership Team - GRAIL
To pursue a mission like GRAIL’s, it takes all of us—a unified collective of courageous, adaptable, and open-minded big thinkers dedicated to creating a better world. Our leadership team strives to push the boundaries of what is …See details»
Grail - Crunchbase Company Profile & Funding
Grail develops a pan-cancer screening test designed to detect cancers at an early stage. Its pan-cancer screening test measures circulating nucleic acids in …See details»
Grail (company) - Wikipedia
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California.It was previously a subsidiary of Illumina started as a startup seeking to develop an early cancer …See details»
The International Grail - The Grail in the USA
The International Grail is a recognized Non-Governmental Organization with consultative status at the United Nations as granted by the Economic and Social Council (ECOSOC), since 1998. ... The Grail in the US is a movement where …See details»
Grail Community - The Grail in the USA
The Grail IS wherever members ARE—with members living in 70+ communities in 23 states and 3 non-US countries. The Grail also continues to operate two campuses: The Bronx Grail Center (New York, NY) and the Loveland Campus …See details»
The Grail (Canada) · 721 - 550 Ontario St, Toronto, ON M4X 1X3
The Grail (Canada) is a charity registered with Canada Revenue Agency (CRA). The fiscal year filed is 1976-05-28. OPEN GOV CA. ... Each charity organization is registered with business …See details»
GRAIL - LinkedIn
GRAIL is headquartered in Menlo Park, California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical ...See details»
Investor Relations - GRAIL, Inc.
Feb 26, 2025 GRAIL has made significant investments over time in technology, growth, and scalability, and we remain focused on our vision of multi-cancer early detection at the …See details»
GRAIL to Begin Trading on the Nasdaq Stock Exchange
MENLO PARK, Calif., June 24, 2024 — GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ: …See details»
How Much Did Grail Raise? Funding & Key Investors | Clay
Despite these challenges, Grail's innovative approach and strong investor support position it well for future success. Use Clay to Get Funding Data. Sales professionals, take your strategy to …See details»
GRAIL Showcases Methylation Platform Performance Across …
Apr 11, 2023 Data Highlight How GRAIL’s Targeted Methylation Technology Can Support Detection of Cancer in Pre-Symptomatic to Post-Diagnosis Settings. MENLO PARK, Calif., …See details»
GRAIL Reports First Quarter 2025 Financial Results - GRAIL, Inc.
1 day ago GRAIL Announces Positive Top-Line Results From the Prevalent Screening Round of the NHS-Galleri Trial Cash Position of $677.9 Million Provides Runway Into 2028 MENLO …See details»
Who We Are - The Grail in the USA
Called by our spiritual values, the Grail envisions a world of peace, justice and renewal of the earth, brought about by racially and ethnically diverse women working together as catalysts for …See details»
GRAIL - Org chart - The Org
Explore GRAIL's organizational chart. Discover current team members including executives, board members, and advisors.See details»
GRAIL to Present New Data on Galleri® and its Methylation …
MENLO PARK, Calif., April 22, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, will present new data …See details»
GRAIL to Announce First Quarter 2025 Financial Results
MENLO PARK, Calif., April 29, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that …See details»
What We Do - The Grail in the USA
The International Grail has had NGO Observer status at the United Nations as part of UFER since 1953, and Special Consultative status through ECOSOC since 1998. Therefore, our US Grail …See details»
GRAIL Overview - GRAIL
Feb 25, 2025 Cookie Notice and Choices. 833-464-7245 ; Get in Touch; Non-Solicitation Statement; Purchase Terms; Social Media Community GuidelinesSee details»
GRAIL Inc (GRAL) Q1 2025 Earnings Call Highlights: Strong …
21 hours ago GRAIL Inc (NASDAQ:GRAL) has a substantial cash position of $677.9 million, with a cash runway extending into 2028, allowing them to achieve major planned clinical and …See details»